See more : Intelsat S.A. (INTEQ) Income Statement Analysis – Financial Results
Complete financial analysis of Ayurcann Holdings Corp. (AYURF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Ayurcann Holdings Corp., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Kerry TJ Logistics Company Limited (2608.TW) Income Statement Analysis – Financial Results
- Adobe Inc. (ADB.DE) Income Statement Analysis – Financial Results
- Domo, Inc. (DOMO) Income Statement Analysis – Financial Results
- Sadot Group Inc. (SDOT) Income Statement Analysis – Financial Results
- Jing-Jan Retail Business Co., Ltd. (2942.TWO) Income Statement Analysis – Financial Results
Ayurcann Holdings Corp. (AYURF)
About Ayurcann Holdings Corp.
Ayurcann Holdings Corp. provides post-harvest outsourcing solutions to licensed cannabis producers in Canada. The company offers end-to-end outsourcing solutions, including extraction and refinement, bulk distillate oil sales, formulation and white label manufacturing, and fulfillment and distribution, as well as customized packaging solutions and inventory management services. It also provides medicinal cannabis, such as tincture, vapes, and topicals. In addition, the company operates Ayurcann marketplace, an online cannabis market for medical cannabis consumers. The company was founded in 2018 and is headquartered in Pickering, Canada.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 12.49M | 9.39M | 7.63M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 8.81M | 7.17M | 3.01M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 3.68M | 2.22M | 4.63M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 29.46% | 23.66% | 60.61% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 5.73M | 5.51M | 2.46M | 0.00 | 196.35K | 218.31K | 209.44K | 324.34K | 261.05K | 411.27K | 610.67K | 101.68K | 0.00 |
| Selling & Marketing | 2.49M | 0.00 | 0.00 | 0.00 | 0.00 | 1.50K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 8.22M | 5.51M | 2.46M | 244.78K | 196.35K | 218.31K | 209.44K | 324.34K | 261.05K | 411.27K | 610.67K | 101.68K | 6.80K |
| Other Expenses | 66.67K | 0.00 | 101.39K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 8.67M | 5.52M | 2.47M | 244.78K | 239.96K | 284.75K | 209.44K | 324.34K | 261.05K | 411.27K | 610.67K | 101.68K | 6.80K |
| Cost & Expenses | 17.48M | 12.68M | 5.47M | 244.78K | 239.96K | 284.75K | 209.44K | 324.34K | 261.05K | 411.27K | 610.67K | 101.68K | 6.80K |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 30.19K | 91.15K | 315.18K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 779.65K | 779.65K | 320.79K | 281.72K | 171.86K | 161.14K | 52.52K | -9.59K | 11.57K | 4.45M | 90.20K | 0.00 | 0.00 |
| EBITDA | -4.14M | -2.97M | 2.54M | -244.78K | -257.10K | -296.73K | -219.03K | -335.07K | -249.47K | 4.04M | -520.47K | -101.68K | -6.80K |
| EBITDA Ratio | -33.18% | -31.68% | 33.31% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -5.34M | -3.33M | 2.16M | -244.78K | -257.10K | -296.73K | -209.44K | -324.34K | -261.05K | -411.27K | -610.67K | -101.68K | -6.80K |
| Operating Income Ratio | -42.78% | -35.50% | 28.29% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | -285.85K | -37.53K | -1.79M | 7.84K | 17.14K | 11.98K | 9.59K | 10.73K | -11.86K | -4.46M | -98.95K | 0.00 | 0.00 |
| Income Before Tax | -5.31M | -3.42M | 57.09K | -236.94K | -222.82K | -272.77K | -199.84K | -313.61K | -272.90K | -4.87M | -709.61K | -101.68K | 0.00 |
| Income Before Tax Ratio | -42.48% | -36.47% | 0.75% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 96.85K | -335.45K | 335.45K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -102.77K | -486.63K | -239.64K | 0.00 | 6.80K |
| Net Income | -5.31M | -3.09M | -278.36K | -236.94K | -222.82K | -272.77K | -199.84K | -313.61K | -170.13K | -4.38M | -469.97K | -101.68K | -6.80K |
| Net Income Ratio | -42.48% | -32.90% | -3.65% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | -0.04 | -0.03 | 0.00 | -0.01 | -0.01 | -0.02 | -0.02 | -0.03 | -0.02 | -0.40 | -0.04 | -0.21 | -0.01 |
| EPS Diluted | -0.04 | -0.03 | 0.00 | -0.01 | -0.01 | -0.02 | -0.02 | -0.03 | -0.02 | -0.40 | -0.04 | -0.21 | -0.01 |
| Weighted Avg Shares Out | 150.12M | 118.51M | 84.99M | 15.86M | 15.86M | 14.29M | 10.86M | 10.86M | 10.86M | 10.86M | 10.86M | 494.67K | 649.94K |
| Weighted Avg Shares Out (Dil) | 150.12M | 118.51M | 84.99M | 15.86M | 15.86M | 14.29M | 10.86M | 10.86M | 10.86M | 10.86M | 10.86M | 494.67K | 649.94K |
AYURCANN HOLDINGS CORP. PROVIDES CORPORATE UPDATE, AND GROWTH STRATEGY
Ayurcann Holdings enters agreement to acquire 100% of Joints and Hustle & Shake for $5.5M
Ayurcann Holdings sees fiscal 3Q revenue rise to $2.8M as it gains more traction in the market
Ayurcann Holdings says it has received its flower sales license amendment from Health Canada effective April 19, 2022
Source: https://incomestatements.info
Category: Stock Reports